Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study-Reference-Cited by-同舟云学术

Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study

Published:2016-02-02 Issue:9 Volume:18 Page:1175-1181
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Chin Ken Lee¹,Collier Timothy J.²,Pitt Bertram³,McMurray John J.V.⁴,Swedberg Karl⁵⁶,van Veldhuisen Dirk J.⁷,Pocock Stuart J.²,Vincent John⁸,Turgonyi Eva⁸,Zannad Faiez⁹,Krum Henry¹,

Affiliation:

1. Centre of Cardiovascular Research & Education in Therapeutics, Department of Epidemiology & Preventive Medicine; Monash University; Melbourne Australia

2. London School of Hygiene and Tropical Medicine; London UK

3. University of Michigan School of Medicine; Ann Arbor MI USA

4. British Heart Foundation Cardiovascular Research Centre; University of Glasgow; Glasgow UK

5. Department of Molecular and Clinical Medicine; University of Gothenburg; Gothenburg Sweden

6. National Heart and Lung Institute; Imperial College; London UK

7. University of Groningen; Groningen The Netherlands

8. Pfizer; New York USA

9. CHU and University Henri Poincaré; Nancy France

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ejhf.485/fullpdf

Reference25 articles.

1. Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) Trial;Al-Khadra;J Am Coll Cardiol,1998

2. Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II);Nguyen;Am J Cardiol,1997

3. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction-results of the Survival and Ventricular Enlargement Trial;Pfeffer;N Engl J Med,1992

4. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure;The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators;Lancet,1993

5. Aspirin does not adversely affect survival in patients with stable congestive heart failure treated with angiotensin-converting enzyme inhibitors;Aumégeat;Chest,2003

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of mineralocorticoid antagonist therapy in heart failure;Pathophysiology, Risk Factors, and Management of Chronic Heart Failure;2024

2. Correction to: Relationship Between Blood Pressure Levels on Admission and the Onset of Acute Pneumonia in Elderly Patients With Cerebral Hemorrhage;Journal of Clinical Medicine Research;2021

3. The Role of Antithrombotic Therapy in Heart Failure;Current Pharmaceutical Design;2020-07-14

4. The new Heart Failure Association journal – ESC Heart Failure;European Journal of Heart Failure;2018-12

5. New Clinical Aspects of Eplerenone Use in Clinical Practice;Rational Pharmacotherapy in Cardiology;2018-09-04